Another study demonstrated that the high expression of miR-200c reversed EMT by direct targeting of ZEB1 and indirect upregulation of E-cadherin by using a crizotinib-resistant lung cancer cell line (NCI-2228/CRI) [155]. The gene discussed is CDH1; the disease is lung cancer.